Earnings Results - Simon Property Group, Inc. is set to release its first-quarter earnings results on May 12, with analysts expecting earnings of $1.36 per share, an increase from $0.84 per share in the same period last year [1] - The company is projected to report quarterly revenue of $1.34 billion, down from $1.44 billion a year earlier [1] Stock Performance - Simon Property shares closed at $163.19, reflecting a gain of 0.1% [2] Analyst Ratings - Deutsche Bank initiated coverage with a Hold rating and a price target of $195 [8] - Evercore ISI upgraded the stock from In-Line to Outperform, raising the price target from $160 to $172 [8] - Stifel downgraded the stock from Buy to Hold, increasing the price target from $157.5 to $159 [8] - Truist Securities maintained a Hold rating and raised the price target from $147 to $158 [8] - Argus Research maintained a Buy rating and increased the price target from $157 to $168 [8] Management Changes - On March 20, Simon Property Group announced the retirement of Independent Director Allan B. Hubbard [1]

Core Viewpoint - Western Digital Corporation is set to release its third-quarter earnings results, with expectations of improved earnings per share but a decline in revenue compared to the previous year [1]. Financial Performance - Analysts predict Western Digital will report earnings of $1.11 per share for the third quarter, an increase from 63 cents per share in the same period last year [1]. - The company is projected to report quarterly revenue of $2.48 billion, down from $3.46 billion a year earlier [1]. Business Developments - On February 24, Western Digital announced the completion of the planned separation of its flash business, Sandisk [2]. Stock Performance - Western Digital shares experienced a decline of 0.7%, closing at $40.62 [3]. Analyst Ratings - Rosenblatt analyst Kevin Cassidy maintained a Buy rating but reduced the price target from $76 to $50 [8]. - Morgan Stanley analyst Joseph Moore kept an Overweight rating while cutting the price target from $93 to $46 [8]. - Benchmark analyst Mark Miller upgraded the stock from Hold to Buy with a price target of $55 [8]. - Mizuho analyst Vijay Rakesh maintained an Outperform rating and lowered the price target from $82 to $68 [8]. - UBS analyst Timothy Arcuri maintained a Neutral rating and reduced the price target from $74 to $50 [8].

Intel Corporation INTC will release earnings results for the first quarter, after the closing bell on Thursday, April 24.Analysts expect the Santa Clara, California-based company to report quarterly earnings at $0 per share, down from 18 cents per share in the year-ago period. Intel projects to report quarterly revenue at $12.30 billion, compared to $12.72 billion a year earlier, according to data from Benzinga Pro.Intel reportedly plans to reduce more than 20% of its workforce as part of a major overhaul u ...

Group 1 - Zions Bancorp reported first-quarter revenue of $795 million, missing analyst estimates of $797.07 million, and earnings of $1.13 per share, below the expected $1.17 per share [1][2] - The company's credit quality remained stable, with nonperforming assets at 0.51% of loans and leases and annualized net charge-offs at 0.11% [2] - The outlook for the economy is uncertain, influenced by potential negative impacts from tariffs and trade policy [2] Group 2 - Zions Bancorp shares fell 1.5% to close at $43.62 following the earnings announcement [3] - Analysts adjusted their price targets for Zions Bancorp, with Stephens & Co. lowering it from $54 to $52, Baird from $58 to $55, and Wells Fargo from $58 to $47 [7]

Johnson & Johnson JNJ will release earnings results for the first quarter, before the opening bell on Tuesday, April 15. Analysts expect the New Brunswick, New Jersey-based company to report quarterly earnings at $2.58 per share, down from $2.71 per share in the year-ago period. Johnson & Johnson projects to report quarterly revenue at $21.57 billion, compared to $21.38 billion a year earlier, according to data from Benzinga Pro. Protagonist Therapeutics, on April 10, announced new data for a pill that trea ...